Company Overview
HERON THERAPEUTICS, INC. /DE/
HRTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-20M
2025 FY
Shares Outstanding
167M
2025 FY
EPS
-0.12USD
2025 FY
Company Information
SIC Code
2834
CIK Code
818033
Exchange
Nasdaq
Location
US